About Drew Pardoll, M.D., Ph.D.
Form D filings for Dracen Pharmaceuticals from 2018 to 2023 list Drew Pardoll, M.D., Ph.D. as director.
Drew Pardoll, M.D., Ph.D. first appears on SEC filings in 2018.
Experience
This experience comes from SEC filings. The years are when the filings name Drew Pardoll, M.D., Ph.D. in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Drew Pardoll, M.D., Ph.D. works with at each company, as listed on that company's latest Form D.
Dracen Pharmaceuticals, Inc. · Form D, Aug 10, 2023